Several members of Congress voiced strong opposition about a reported plan to create a panel of political appointees to sign off on NIH grants ...

Shares in Grail, the company developing a blood test for cancer, surged Monday after the FDA posted documents ahead of an advisory committee meeting.

Under investor pressure, Novo presented its strategy to both grow its obesity franchise and diversify its pipeline.

A day after health secretary Robert F. Kennedy Jr. promised that parents concerned about vaccines had a “friend” in the White House, President Trump said he’ll be “demanding” that drug companies split ...

The FDA just approved a new combination drug treatment for patients with an advanced form of breast cancer.

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Senate leadership on ...

Lev’s reporting has explored Americans’ deadly hostility to addiction medications, subpar treatment offered in jails and prisons, shifts in the illicit drug supply and consumption behavior, ...

Over the past 25 years, there’s been a dramatic change in how we understand children who don’t “listen,” writes behavioral ...

Before passing their tax-cut law, they added in $50 billion over the next five years. This rural health fund was intended to ...

The FDA is opening applications for a pilot program designed to shorten drug approval timelines and help the U.S. compete ...

We’re very actively hiring,” Karim Mikhail, director of FDA’s Center for Biologics Evaluation and Research, told drug ...